The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.
A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are ...
The growth has been driven by advancements in biotechnology, agricultural innovation, bio-manufacturing, and healthcare, the ...
The erythropoietin drugs market was valued at $9,243.12 million in 2020, and is projected to reach $ 14,414.59 million by 2028, registering a CAGR of 5.7% from 2021 to 2028. Rise in number of patients ...
Researchers from the J. Craig Venter Institute (JCVI), the Friedrich-Loeffler-Institut (FLI), and the International Livestock ...
CRISPR, The New Gold Standard?Understanding The Rise Of Genetic Engineering In India – Part 2. Legal News and Analysis - ...
A recent study estimates if ASFV reached the United States it could result in economic losses exceeding $50 billion over a ten-year period.
R&D Expenses: Research and development expenses for the year ended December 31, 2024 decreased to approximately $2,044,000 ...
News-Medical.Net on MSN2d
Researchers develop a reverse genetics system for African swine fever virusResearchers from the J. Craig Venter Institute (JCVI), the Friedrich-Loeffler-Institut (FLI), and the International Livestock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback